Company intelligence / Profile preview

BioStem Technologies

Pompano Beach, Florida, United Statesbiostemtechnologies.com ↗

Ownership: Private
Development stage: Other

Overview

BioStem Technologies has achieved commercial success with its placental-derived allograft products such as VENDAJE®, VENDAJE AC®, VENDAJE OPTIC®, and AmnioWrap2™. The company is running pivotal multicenter clinical trials in diabetic foot ulcers to demonstrate superiority over standard of care, aiming to support broader insurance coverage and market expansion. Early results have driven significant revenue growth, but full trial outcomes are pending.[5][6][9]

Therapeutic areas: EndocrinologyPsychiatryDermatology
Modalities: Perinatal tissue allograftsPlacental-derived biologics
Industry: Biotech

Drug pipeline

8 assets

BSEM-002

Preclinical

7 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on BioStem Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioStem Technologies.

Explore the full profile